Symbol="TVTX"
AssetType="Common Stock"
Name="Travere Therapeutics Inc"
Description="Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development and commercialization of therapies for the treatment of rare diseases. The company is headquartered in San Diego, California."
CIK="1438533"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="777 THIRD AVENUE 22ND FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="958234000"
EBITDA="-258668992"
PERatio="None"
PEGRatio="None"
BookValue="1.554"
DividendPerShare="0"
DividendYield="0"
EPS="-4.2"
RevenuePerShareTTM="3.318"
ProfitMargin="-1.36"
OperatingMarginTTM="-1.327"
ReturnOnAssetsTTM="-0.247"
ReturnOnEquityTTM="-2.251"
RevenueTTM="226054000"
GrossProfitTTM="-31354000"
DilutedEPSTTM="-4.2"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.102"
AnalystTargetPrice="26.93"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="5.56"
PriceToBookRatio="11.94"
EVToRevenue="5.17"
EVToEBITDA="-4.999"
Beta="0.417"
num_52WeekHigh="28.38"
num_52WeekLow="12.57"
num_50DayMovingAverage="15.67"
num_200DayMovingAverage="19.0"
SharesOutstanding="75011000"
DividendDate="None"
ExDividendDate="None"
symbol="TVTX"
open="12.79"
high="13.26"
low="12.63"
price="13.23"
volume="1160943.00"
latest_trading_day="2023-08-24"
previous_close="12.72"
change="0.51"
change_percent="4.0094%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="98"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="2"
Volume_recent_avg="1217789"
Change_recent_avg="-0.05"
Delta_recent_avg="0.78"
Variance_recent_avg="0.39"
Change_ratio_recent_avg="-0.32"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="2"
Aroon_momentum_negative="98"
image_negative_thumbnail_id_1="1093"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0126.jpeg"
image_negative_thumbnail_id_2="106"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0070.jpeg"
image_neutral_thumbnail_id_1="525"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_neutral_thumbnail_id_2="555"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_positive_thumbnail_id_1="663"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0045.jpeg"
image_positive_thumbnail_id_2="954"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0116.jpeg"
image_professor_thumbnail_id_1="1196"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
image_professor_thumbnail_id_2="1191"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
